Annual Long Term Debt
$25.78 M
+$15.16 M+142.78%
December 31, 2023
Summary
- As of February 7, 2025, AKRO annual long term debt is $25.78 million, with the most recent change of +$15.16 million (+142.78%) on December 31, 2023.
- During the last 3 years, AKRO annual long term debt has risen by +$24.27 million (+1600.73%).
- AKRO annual long term debt is now at all-time high.
Performance
AKRO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$35.73 M
+$90.00 K+0.25%
September 30, 2024
Summary
- As of February 7, 2025, AKRO quarterly long term debt is $35.73 million, with the most recent change of +$90.00 thousand (+0.25%) on September 30, 2024.
- Over the past year, AKRO quarterly long term debt has increased by +$12.07 million (+51.03%).
- AKRO quarterly long term debt is now at all-time high.
Performance
AKRO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AKRO Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +142.8% | +51.0% |
| 3 y3 years | +1600.7% | +2517.4% |
| 5 y5 years | - | - |
AKRO Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1866.7% | at high | +2746.8% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Akero Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $35.73 M(+0.3%) |
| Jun 2024 | - | $35.64 M(+0.2%) |
| Mar 2024 | - | $35.55 M(+37.9%) |
| Dec 2023 | $25.78 M(+142.8%) | $25.78 M(+9.0%) |
| Sep 2023 | - | $23.66 M(-7.9%) |
| Jun 2023 | - | $25.68 M(+0.2%) |
| Mar 2023 | - | $25.63 M(+141.4%) |
| Dec 2022 | $10.62 M | $10.62 M(+0.3%) |
| Sep 2022 | - | $10.59 M(+0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $10.56 M(+741.8%) |
| Mar 2022 | - | $1.25 M(-4.3%) |
| Dec 2021 | $1.31 M(-13.5%) | $1.31 M(-4.0%) |
| Sep 2021 | - | $1.36 M(-3.7%) |
| Jun 2021 | - | $1.42 M(-3.4%) |
| Mar 2021 | - | $1.47 M(-3.2%) |
| Dec 2020 | $1.52 M(>+9900.0%) | $1.52 M(-3.1%) |
| Sep 2020 | - | $1.56 M(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is Akero Therapeutics annual long term debt?
- What is the all time high annual long term debt for Akero Therapeutics?
- What is Akero Therapeutics annual long term debt year-on-year change?
- What is Akero Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Akero Therapeutics?
- What is Akero Therapeutics quarterly long term debt year-on-year change?
What is Akero Therapeutics annual long term debt?
The current annual long term debt of AKRO is $25.78 M
What is the all time high annual long term debt for Akero Therapeutics?
Akero Therapeutics all-time high annual long term debt is $25.78 M
What is Akero Therapeutics annual long term debt year-on-year change?
Over the past year, AKRO annual long term debt has changed by +$15.16 M (+142.78%)
What is Akero Therapeutics quarterly long term debt?
The current quarterly long term debt of AKRO is $35.73 M
What is the all time high quarterly long term debt for Akero Therapeutics?
Akero Therapeutics all-time high quarterly long term debt is $35.73 M
What is Akero Therapeutics quarterly long term debt year-on-year change?
Over the past year, AKRO quarterly long term debt has changed by +$12.07 M (+51.03%)